As CASPR2 mAbs are sufficient for pathogenic effects at the molecular level, abnormal CASPR2 function may also occur in autoantibody-positive patients without encephalitis, suggesting the potential contribution of low-level CASPR2 autoantibodies to further neuropsychiatric symptoms. This evidence concerns the gene CNTNAP2 and viral encephalitis.